| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Jun 30, 2026 | Option exercise(M) | 814 | $4.14 | $3K | 9K |
| Jun 30, 2026 | Option exercise(M) | 6K | $6.49 | $37K | 15K |
| Jun 30, 2026 | Sell(S) | 7K | $14.00 | $92K | 9K |
| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Jun 30, 2026 | Option exercise(M) | 814 | — | $0 | 63K |
| Jun 30, 2026 | Option exercise(M) | 6K | — | $0 | 4K |
Parsed from a single SEC EDGAR Form 4 filing (accession 0001920738-26-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for 4D Molecular Therapeutics, Inc.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.